Full Text View
Tabular View
No Study Results Posted
Related Studies
Vulvar Vestibulitis Clinical Trial: Desipramine-Lidocaine
This study has been completed.
Study NCT00276068   Information provided by University of Rochester
First Received: January 11, 2006   Last Updated: November 12, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Vulvar Disease
Additional conditions recognized in this trial
Vulvar Diseases
Vulvar Vestibulitis
More general conditions related to this trial
Genital Diseases, Female
Vulvitis
Additional drug interventions recognized in this trial
Desipramine
Lidocaine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Uptake Inhibitors
Anesthetics
Anesthetics, Local
Anti-Arrhythmia Agents
Antidepressive Agents
Antidepressive Agents, Tricyclic
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Rochester


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services